Nexalin holders back reverse split and equity plan
Nexalin Technology, Inc. held its annual stockholder meeting on August 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nexalin Technology, Inc. held its annual stockholder meeting on August 11, 2026. Of 22,011,302 common shares outstanding as of July 6, 2026, 13,912,110 shares, or about 63.2%, were present, establishing a quorum. Stockholders elected five directors and approved the 2026 Equity Incentive Plan. They also approved amendments authorizing the board, in its discretion, to implement one or more reverse stock splits of the common stock, with ratios ranging from 1-for-2 to 1-for-100 and in the aggregate not more than 1-for-250. An amendment to authorize 10 million shares of preferred stock and an amendment to provide for Officer Exculpation did not receive sufficient support. Stockholders ratified the appointment of CBIZ CPAS P.C. as independent registered public accounting firm for the year ending December 31, 2026.
Positive
- Reverse stock split flexibility approved: Stockholders authorized one or more reverse stock splits between 1-for-2 and 1-for-100, in the aggregate not more than 1-for-250, giving the board structural capital flexibility.
- Equity plan and auditor ratified: The 2026 Equity Incentive Plan and the appointment of CBIZ CPAS P.C. as independent registered public accounting firm for 2026 both received stockholder approval.
Negative
- Preferred stock authorization rejected: Stockholders did not approve creating 10 million shares of preferred stock, limiting the company’s ability to use preferred equity for financing or structural purposes.
- Officer exculpation amendment failed: Stockholders did not approve adding Officer Exculpation to the charter, leaving officers without the additional limitation on personal monetary liability that had been proposed.
8-K Event Classification
Key Figures
Key Terms
reverse stock split financial
broker non-votes financial
Equity Incentive Plan financial
Officer Exculpation regulatory
independent registered public accounting firm financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the quorum and turnout at Nexalin Technology (NXL) 2026 annual meeting?
Which director nominees were elected at Nexalin Technology (NXL) on August 11, 2026?
Did Nexalin Technology (NXL) stockholders approve a reverse stock split authority?
Was Nexalin Technology’s (NXL) 2026 Equity Incentive Plan approved?
Who is Nexalin Technology’s (NXL) independent auditor for 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.